HemaSphere
(Jun 2022)
PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
- J.-F. Bai,
- J. T. Li,
- R. Feng,
- L. Qian,
- J. Yin,
- H. Liu
Affiliations
- J.-F. Bai
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- J. T. Li
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- R. Feng
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- L. Qian
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- J. Yin
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- H. Liu
- 1 Beijing Hospital, National Center of Gerontology, P.R. China., Beijing, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000851220.50282.7c
- Journal volume & issue
-
Vol. 6
pp.
1968
– 1969
WeChat QR code